The fine line between familial and polygenic hypercholesterolemia

References

• Goldstein J, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS et al. (Eds). Mc Graw-Hill, NY, USA, 2863–2913 (2001).
   Google Scholar
• Scientific Steering Committee on behalf of the Simon Broome Register Group: risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 303(6807), 893–896 (1991).
   Google Scholar
• Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173(1), 55–68 (2004). International expert panel position on the definition, diagnosis and treatment of familial hypercholesterolemia.
   Google Scholar
• Civeira F, Ros E, Jarauta E et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am. J. Cardiol. 102(9), 1187–1193 (2008).
   Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010). Authors screened the genome for common variants associated with plasma lipids in >100,000 individuals of European ancestry. They report 95 loci with genome-wide significant association with lipids.
   Google Scholar
• Talmud PJ, Shah S, Whittall R et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic hypercholesterolaemia: a case–control study. Lancet 381(9874), 1293–1301 (2013).
   Google Scholar
• Marmot MG, Smith GD, Stansfeld S et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 337(8754), 1387–1393 (1991).
   Google Scholar
• Bennet AM, Di Angelantonio E, Ye Z et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298(11), 1300–1311 (2007).
   Google Scholar
• Marduel M, Ouguerram K, Serre V et al. Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation. Hum. Mutat. 34(1), 83–87 (2013).
   Google Scholar
• Solanas-Barca M, de Castro-Orós I, Mateo-Gallego R et al. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia. Atherosclerosis 222(2), 449–455 (2012).
   Google Scholar
• Cenarro A, García-Otín AL, Tejedor MT et al. A presumptive new locus for autosomal dominant hypercholesterolemia mapping to 8q24.22. Clin. Genet. 79(5), 475–481 (2011).
   Google Scholar
• Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 303(6807), 893–896 (1991).
   Google Scholar
• Williams RR, Hunt SC, Schumacher MC et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am. J. Cardiol. 72(2), 171–176 (1993).
   Google Scholar
• Defesche J. Familial hypercholesterolemia. In: Lipids and Vascular Disease. Betteridge J (Ed.). Martin Dunitz, London, UK, 6, 65–76 (2000).
   Google Scholar
• Civeira F, Jarauta E, Cenarro A et al. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. J. Am. Coll. Cardiol. 52(19), 1546–1553 (2008).
   Google Scholar
• Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in The Netherlands. Lancet 357(9251), 165–168 (2001).
   Google Scholar
• Wierzbicki AS, Humphries SE, Minhas R. Guideline Development Group. Familial hypercholesterolaemia: summary of NICE guidance. BMJ 337, 1095 (2008). Recent review of and practical guidelines for clinical aspects of familial hypercholesterolemia, and its management.
   Google Scholar
• De Castro-Orós I, Pocoví M, Civeira F. The genetic basis of familial hypercholesterolemia, inheritance, linkage, and mutations. Appl. Clin. Genet. 3(1), 53–64 (2010). Reviews the genes, genetic transmission and mechanism involved in the different forms of autosomal dominant hypercholesterolemias.
   Google Scholar